Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Pediatric Dermatology|June 26, 2008
Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitisRichard G B Langley, Lawrence F Eichenfield, Anne W Lucky, et al.
Pediatrics|November 25, 2015
Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE MeasurementsJonathan M Spergel, Mark Boguniewicz, Lynda Schneider, et al.
Pediatric Dermatology|June 9, 2016
Study of the Atopic March: Development of Atopic ComorbiditiesLynda Schneider, Jon Hanifin, Mark Boguniewicz, et al.
Clinical Immunology (Orlando, Fla.)|October 4, 2006
Mechanism of HBD-3 deficiency in atopic dermatitisMichael D Howell, Mark Boguniewicz, Saveria Pastore, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 6, 2021
Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US AdultsJonathan Ian Silverberg, Zelma Chiesa-Fuxench, David Margolis, et al.
Dermatology and Therapy|October 21, 2022
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical TrialsJonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, et al.
Pediatrics|September 6, 2005
Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled studyLawrence A Schachner, Cindy Lamerson, Mary P Sheehan, et al.
The Journal of Investigative Dermatology|April 27, 2007
The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3Kevin O Kisich, Michael D Howell, Mark Boguniewicz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 24, 2025
Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbiditiesAmy S Paller, Weily Soong, Mark Boguniewicz, et al.
Pharmacoeconomics|June 18, 2005
The economics of topical immunomodulators for the treatment of atopic dermatitisWilliam Abramovits, Mark Boguniewicz, Amy S Paller, et al.
Pageof 15